Inactivation of VEGF during development results in embryonic lethality and myocardial defects [5,6], whereas VEGF delivery has been shown to induce new vascular growth and improved cardiac function in preclinical models of myocardial infarction [7]. Here, VEGFA is linked to myocardial infarction.